MedTrace Logo

Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation

NCT00856817 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2011-08-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether heme oxygenase 1 induction by heme arginate treatment is of influence on adenosine induced vasodilation in healthy individuals.

Conditions

Interventions

DRUG

L-arginine + heme arginate

L-arginine first, heme arginate second three day treatment

DRUG

Heme arginate + L-arginine

Heme arginate first, L-arginine second three day treatment

Sponsors & Collaborators

  • Dutch Diabetes Research Foundation

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00856817 on ClinicalTrials.gov